Arginine methylation controls growth regulation by E2F-1
Open Access
- 10 February 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in The EMBO Journal
- Vol. 31 (7), 1785-1797
- https://doi.org/10.1038/emboj.2012.17
Abstract
E2F transcription factors are implicated in diverse cellular functions. The founding member, E2F‐1, is endowed with contradictory activities, being able to promote cell‐cycle progression and induce apoptosis. However, the mechanisms that underlie the opposing outcomes of E2F‐1 activation remain largely unknown. We show here that E2F‐1 is directly methylated by PRMT5 (protein arginine methyltransferase 5), and that arginine methylation is responsible for regulating its biochemical and functional properties, which impacts on E2F‐1‐dependent growth control. Thus, depleting PRMT5 causes increased E2F‐1 protein levels, which coincides with decreased growth rate and associated apoptosis. Arginine methylation influences E2F‐1 protein stability, and the enhanced transcription of a variety of downstream target genes reflects increased E2F‐1 DNA‐binding activity. Importantly, E2F‐1 is methylated in tumour cells, and a reduced level of methylation is evident under DNA damage conditions that allow E2F‐1 stabilization and give rise to apoptosis. Significantly, in a subgroup of colorectal cancer, high levels of PRMT5 frequently coincide with low levels of E2F‐1 and reflect a poor clinical outcome. Our results establish that arginine methylation regulates the biological activity of E2F‐1 activity, and raise the possibility that arginine methylation contributes to tumourigenesis by influencing the E2F pathway.Keywords
This publication has 45 references indexed in Scilit:
- Discovery of Candidate Serum Proteomic and Metabolomic Biomarkers in Ankylosing SpondylitisMolecular & Cellular Proteomics, 2012
- Nuclear Cyclin D1/CDK4 Kinase Regulates CUL4 Expression and Triggers Neoplastic Growth via Activation of the PRMT5 MethyltransferaseCancer Cell, 2010
- Phase III Randomized Trial Assessing Rofecoxib in the Adjuvant Setting of Colorectal Cancer: Final Results of the VICTOR TrialJournal of Clinical Oncology, 2010
- Crosstalk between C/EBPβ phosphorylation, arginine methylation, and SWI/SNF/Mediator implies an indexing transcription factor codeThe EMBO Journal, 2010
- The DNA-damage response in human biology and diseaseNature, 2009
- Protein Arginine Methylation in Mammals: Who, What, and WhyMolecular Cell, 2009
- E2F – at the crossroads of life and deathTrends in Cell Biology, 2008
- DNA‐damage response control of E2F7 and E2F8EMBO Reports, 2008
- Life and death decisions by the E2F transcription factorsCurrent Opinion in Cell Biology, 2007
- E2F1-induced apoptosis: turning killers into therapeuticsTrends in Molecular Medicine, 2006